Table 2 Saturation grid: Decision attributes considered in CHC treatment decisions (n = 29)
Decision Attribute | n | % |
|---|---|---|
Physical side effects | 24 | 83Â % |
Efficacy/Cure rate | 23 | 79Â % |
New drugs in development | 16 | 55Â % |
Psychological/Mental health side effects | 16 | 55Â % |
Condition of liver | 15 | 52Â % |
Treatment regimen | 12 | 41Â % |
Support network/family help | 12 | 41Â % |
Other illnesses | 12 | 41Â % |
Quality of life | 11 | 38Â % |
Length of treatment | 9 | 31Â % |
Financial pressures/being able to work | 7 | 24Â % |
Age/life span | 7 | 24Â % |
Doctor’s recommendation | 7 | 24 % |
Medical privacy/stigma | 7 | 24Â % |
Fear of transmitting illness | 6 | 21Â % |
Urgency to treat | 6 | 21Â % |
Trust in provider | 5 | 17Â % |
Travel to VHA | 5 | 17Â % |
Location/stability of living situation | 5 | 17Â % |
Caregiver responsibilities | 4 | 14Â % |
Quitting drinking/drugs | 4 | 14Â % |
Not wanting biopsy | 3 | 10Â % |
Other people’s experiences with treatment | 3 | 10 % |
Using alternate/natural treatment/herbs | 3 | 10Â % |